10X Genomics Inc

$49.53 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About 10X Genomics Inc

10x Genomics, Inc. is a life science technology company. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company’s product consists of chromium single cell gene expression solution, cell immune profiling solution, cell copy number variation (CNV) solution, Cell assay for transposase accessible chromatin (ATAC) solution. The Company’s Chromium platform enables analysis of individual biological components, such as up to millions of single cells. Its Visium platform is designed to identify where biological components are located and how they are arranged with respect to each other. Its molecular assays are used with its Chromium platform, and with its planned Visium platform, to provide sensitive and robust biochemistries that convert minute amounts of biological analytes into detectable signals.

Stock Analysis

last close $49.58
1-mo return 10.3%
3-mo return -32.6%
avg daily vol. 1.45M
52-week high 192.92
52-week low 35.15
market cap. $4.4B
forward pe -
annual div. -
roe -11.4%
ltg forecast -
dividend yield -
annual rev. $499M
inst own. 99.4%

Subscribe now for daily local and international financial news